Champions Oncology, Inc.
CSBR
Positions held
Your positionsCSBR isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | $69.31M | Enterprise value | $76.49M | Trailing P/E | — | Forward P/E | 49.80 |
| PEG | — | Price / book | 17.79 | Beta | 0.44 | Dividend yield | 0.00% |
| Revenue growth | 8.8% | Earnings growth | — | Gross margin | 49.8% | Operating margin | -2.7% |
| Profit margin | -1.9% | ROE | -28.4% | ROA | -1.8% | Debt / equity | 2.46 |
| Current ratio | 1.03 | Free cash flow | -$5.49M | Analyst recommendation | none | Mean target | — |
| 52w high | $8.31 | 52w low | $4.59 |
Quarterly
| 2026-Q3 | 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | |
|---|---|---|---|---|---|---|
| Revenue | $15.2M | $13.8M | $16.6M | $15.0M | $14.0M | — |
| Op margin | -2.7% | -3.8% | -1.1% | 1.2% | -3.6% | — |
| Net income | -$0.4M | -$0.7M | -$0.3M | $0.3M | -$0.5M | — |
| Gross margin | 50.5% | 50.8% | 46.7% | 51.7% | 42.9% | — |
| Gross profit | $7.7M | $7.0M | $7.7M | $7.8M | $6.0M | — |
| Operating income | -$0.4M | -$0.5M | -$0.2M | $0.2M | -$0.5M | — |
- Revenue +10% vs prior quarter ($15M vs $14M).
- Gross margin 50.5% (was 50.8% prior quarter).
- Operating margin expanded to -2.7%.
Yearly (6y)
| 2026 | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Revenue | $59.4M | $56.9M | $50.2M | $53.9M | — |
| Op margin | -1.7% | 8.5% | -13.8% | -8.3% | — |
| Net income | -$1.2M | $4.7M | -$7.3M | -$5.3M | — |
| Gross margin | 48.0% | 50.1% | 41.4% | 45.2% | — |
| Gross profit | $28.5M | $28.6M | $20.8M | $24.3M | — |
| Operating income | -$1.0M | $4.8M | -$6.9M | -$4.4M | — |
Headlines — positive tone
• [OK · fundamentals] Champions Oncology Inc (CSBR) (Q4 2026) Earnings Call Highlights: Record Revenue and Positive ...
• [OK · fundamentals] CSBR Stock Dips Post Q4 Earnings Despite Record Revenue Growth, AI Push
News
2026-09-15 · CSBR Stock Slips Post Q1 Earnings Despite Revenue, Margin Growth
2026-09-15 · Champions Oncology Inc (CSBR) (Q1 2027) Earnings Call Highlights: Data Licensing Surge and ...
2026-09-11 · Champions Oncology (CSBR) Q1 2027 Earnings Call Transcript
2026-09-11 · Champions Oncology, Inc. Q1 2027 Earnings Call Summary
2026-09-10 · Champions Oncology Q1 Earnings Call Highlights
2026-09-10 · Champions Oncology Reports Revenue of $15.2 Million
2026-09-04 · Champions Oncology to Announce First Quarter Financial Results on Thursday, September 10, 2026
2026-07-30 · CSBR Stock Dips Post Q4 Earnings Despite Record Revenue Growth, AI Push
2026-07-30 · Champions Oncology Inc (CSBR) (Q4 2026) Earnings Call Highlights: Record Revenue and Positive ...
2026-07-27 · Champions Oncology Q4 Earnings Call Highlights
2026-07-27 · Champions Oncology Reports Record Annual Revenue of $59 Million
Price (daily)
Full chart · RSI · MACD · patterns